Synthesis of cinnamils and quinoxalines and their biological evaluation as anticancer agents
作者:Ruei‐Yu Wang、Cai‐Wei Li、Shu‐Tse Cho、Chun‐Hao Chang、Jih‐Jung Chen、Tzenge‐Lien Shih
DOI:10.1002/ardp.202100448
日期:2022.5
We synthesized multiple cinnamils and quinoxalines to evaluate their anticancer activity. Cinnamils were used as precursors for quinoxalines via condensation with 1,2-diaminobenzene. Among the 26 synthesized compounds reported in this article, we found that cinnamil 3l exhibited its inhibitory effect with an IC50 value of 1.45 ± 0.98 μM, significantly higher than doxorubicin (8.5 ± 0.85 μM) against
我们合成了多种肉桂和喹喔啉来评估它们的抗癌活性。肉桂醛通过与 1,2-二氨基苯缩合用作喹喔啉的前体。在本文报道的26种合成化合物中,我们发现cinnamil 3l对胰腺癌细胞(PANC-1)表现出抑制作用,其IC 50值为1.45 ± 0.98 μM,显着高于多柔比星(8.5 ± 0.85 μM)。此外,cinnamil 3l (IC 50 10.98 ± 3.63 μM) 对 Hs68 细胞的细胞毒性低于阿霉素 (0.92 ± 1.11 μM)。集落形成实验表明3l明显降低PANC-1细胞活力,Western blot实验证实3l通过Bax、Bcl-2和caspase 3信号级联反应显着诱导PANC-1细胞凋亡。这些结果表明,cinnamil 3l具有进一步开发为胰腺癌有前途的化疗药物的巨大潜力。